Skip to content

Reduction of Cardiovascular Risk in Severe Mental Illness

Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01182012
Acronym
RISCA-TMS
Enrollment
391
Registered
2010-08-16
Start date
2010-08-31
Completion date
2012-12-31
Last updated
2010-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective Disorders, Bipolar Disorder, Personality Disorder, Schizoaffective Disorder, Schizophrenia, Severe Mental Illness

Keywords

Cardiovascular risk factor, Severe mental illness, Drug appropriateness, Drug compliance, Lifestyle counseling

Brief summary

Background: Patients with severe mental illness (SMI) have a higher prevalence of cardiovascular risk factors (CVRF) than the general population and a control of these risk factors poorer. Serious mental illness often causes health teams to focus interventions in mental illness and put aside the CVRF. Objectives: This project aims to assess the CVRF, stratify the cardiovascular risk, adequate drug treatment to reduce this risk and evaluate the effectiveness of an intervention by professional community nurses in patients with SMI. Materials and Methods: Prospective study of a cohort of patients over 18 years with a diagnosis of SMI with two cross sections to evaluate the cardiovascular risk and adequacy of drug treatment. The investigators calculate the risk to the cardiovascular risk tables with the SCORE (Systematic Coronary Risk Evaluation) for countries of low cardiovascular risk and the of Framingham REGICOR (Heart registry of Girona, Spain). The adequacy of pharmacotherapy will be assessed contrasting it with the recommendations of the Program of Preventive Activities and Health Promotion of Family medical association. The intervention will be conducted by professional nurses and consist of an initial psycho-educational intervention, and two more reinforcement throughout twelve months, of duration less than 30 minutes that will be addressed in an integrated manner the clinical situation with regard to cardiovascular risk. If necessary, pharmacological treatment will be prescribed. Twelve months after the first intervention, a second evaluation on cardiovascular risk and the effectiveness of the intervention will be performed.

Interventions

BEHAVIORALLifestyle counseling

Depending on the results of cardiovascular risk factor indexes, the treatment (including drugs, if needed) may be modified or adjusted. A nurse visit will be programmed to explain the lifestyle behaviour the patient should have.

Sponsors

Institut Catala de Salut
CollaboratorOTHER_GOV
Consorci Hospitalari de Vic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a severe mental illness as schizophrenia, bipolar disorder, affective disorder, schizoaffective disorder or personality disorder and others who receive clinical follow-up in Osona (a county) mental health center. * Inclusion will be delayed in patients with acute psychiatric symptoms.

Exclusion criteria

* Renal or hepatic failure, metabolic or endocrine disorder * Patients who do not accept to participate

Design outcomes

Primary

MeasureTime frameDescription
Reduction of cardiovascular riskAfter one year of inclusionTo collect the Systematic coronary risk evaluation (SCORE) index adapted for low-risk countries and the REGICOR index (an adaptation on the Framingham cardiovascular risk function) for each patient twice at inclusion and after one year of follow-up. To calculate and to analyse the changes between the two moments.

Secondary

MeasureTime frameDescription
Normalization of cholesterolemiaAfter one year of inclusionAn analysis will be made to see if initial abnormal cholesterolemia blood levels have been normalized at the end of study.
Control of hiperglycaemiaAfter one year of inclusionAn analysis will be made to see if initial abnormal glycose blood levels (and if diabetes was diagnosticated) have been normalized at the end of study.
Normalization of blood pressureAfter one year of inclusionAn analysis will be made to see if initial abnormal blood pressure levels have been normalized at the end of study.
Euro-Qol indexAfter one year of inclusionTo compare Euro-Qol index quality of life questionnaire obtained twice, at inclusion and after one year of follow-up.
Seville quality of life questionnaire (SQLQ)After one year of inclusionSeville quality of life questionnaire has proven to be a valid sensitive instrument to measure quality of life in schizophrenic patients. It focuses on aspects that are relevant for patients that were frequently overlooked by treating physicians. To compare SQLQ index obtained twice, at inclusion and after one year of follow-up.
Smoking cessationAfter one year of inclusionAt the end of follow-up an study about smoking cessation will be made.

Countries

Spain

Contacts

Primary ContactPere Roura-Poch, MD
proura@chv.cat+34.937.02.77.13

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026